Top compounds associated with response to U2AF1


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC 0.04 0.3
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.058 0.3
mRNA VU0155056 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA canertinib CTRPv2 pan-cancer AAC -0.041 0.3
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.037 0.3
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.06 0.3
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.04 0.3
Download CSV